Related Experiment Video
Updated: Jan 5, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
Published on: June 4, 2012
Eustachian valve endocarditis
Jerry Fan1, Phuong Tram N Le2, Billy Don Jones2
1Department of Internal Medicine, Baylor Scott & White HospitalTempleTexas.
Abstract:
Eustachian valve infective endocarditis is rare and mostly affects intravenous drug abusers and those with implanted medical devices or indwelling central venous catheters. The most commonly identified organism is Staphylococcus aureus. Treatment includes intravenous antibiotics for approximately 6 weeks. We present a case of Staphylococcus aureus Eustachian valve endocarditis in an individual without traditional risk factors.
Insights
Infective endocarditis of the Eustachian valve is uncommon, typically seen in intravenous drug users. This case highlights Staphylococcus aureus Eustachian valve endocarditis in a patient lacking typical risk factors.
Area of Science:
- Cardiology
- Infectious Diseases
- Medical Case Reports
Background:
- Eustachian valve infective endocarditis (EVIE) is a rare condition.
- It predominantly affects individuals with specific risk factors such as intravenous drug abuse, implanted medical devices, or central venous catheters.
- Staphylococcus aureus is the most frequently implicated pathogen in EVIE.
Observation:
- This report details a unique case of Staphylococcus aureus EVIE.
- The affected individual presented without any of the traditional risk factors typically associated with this condition.
- This challenges the conventional understanding of EVIE etiology.
Findings:
- The study identifies Staphylococcus aureus as the causative agent.
- It underscores the possibility of EVIE occurring in individuals without established risk factors.
- The case emphasizes the need for broader diagnostic considerations.
Implications:
- This case broadens the spectrum of patients susceptible to Eustachian valve endocarditis.
- It suggests that clinicians should consider EVIE even in the absence of typical risk factors.
- Further research may be warranted to explore non-traditional risk factors and diagnostic pathways for EVIE.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis IV: Nursing Management
Mitral Stenosis I: Introduction
Rheumatic Heart Disease I: Introduction

